1428640-11-2

Upstream product

• 100959-22-6 methyl 2-bromo-4-nitrobenzoate 
• 1993-03-9 o-fluorophenylboronic acid 
• 358-23-6 trifluoromethylsulfonic anhydride 
• 1428640-10-1 methyl 3-(2-fluorophenyl)-8-hydroxy-6H-benzo[c]chromene-2-carboxylate 
• 1428640-09-8 methyl 3-(2-fluorophenyl)-8-isopropoxy-6H-benzo[c]chromene-2-carboxylate 
• 1428640-08-7 methyl 5-(2-bromo-5-isopropoxybenzyloxy)-2'-fluorobiphenyl-2-carboxylate 
• 1428640-07-6 1-bromo-2-(chloromethyl)-4-isopropoxybenzene 
• 1428640-06-5 methyl (2-bromo-5-isopropoxyphenyl)methanol 
• 1428640-05-4 2-bromo-5-isopropoxybenzyl acetate 
• 26066-15-9 3-isopropoxybenzyl alcohol 
• 620-24-6 3-Hydroxybenzyl alcohol 
• 1428639-88-6 methyl 2'-fluoro-5-hydroxybiphenyl-2-carboxylate 
• 1428639-87-5 methyl 5-amino-2'-fluorobiphenyl-2-carboxylate 
• 1428639-86-4 methyl 2'-fluoro-5-nitrobiphenyl-2-carboxylate 

Downstream Products

• 1428640-14-5 3-(2-fluorophenyl)-8-(morpholine-4-carbonyl)-6H-benzo[c]chromene-2-carboxylic acid 
• 1428639-44-4 3-(2-fluorophenyl)-N-((R)-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl)-8-(morpholine-4-carbonyl)-6H-benzo[c]chromene-2-carboxamide 
• 1428640-16-7 methyl 8-(dimethylcarbamoyl)-3-(2-fluorophenyl)-6H-benzo[c]chromene-2-carboxylate 
• 1428640-13-4 methyl 3-(2-fluorophenyl)-8-(morpholine-4-carbonyl)-6H-benzo[c]chromene-2-carboxylate 
• 1428640-15-6 3-(2-fluorophenyl)-2-(methoxycarbonyl)-6H-benzo[c]chromene-8-carboxylic acid 

Relevant academic research and scientific papers

FSH RECEPTOR ANTAGONISTS

The invention relates to FSH receptor antagonist according to general formula I or a pharmaceutically acceptable salt thereof and to a pharmaceutical composition containing the same. The compounds can be used for the treatment and prevention of endometriosis, for the treatment and prevention of pre-menopausal and peri-menopausal hormone-dependent breast cancer, for contraception, and for the treatment of uterine fibroids and other menstrual-related disorders.